logo

For the Inventor, By the Inventor

Middleton, WI, United States of America

Vladimir G Budker

This inventor holds 59 USPTO granted patents and 3 EPO patents, primarily in Nucleic Acid Delivery (CPC class A61K). Top assignees: Mirus Bio Corporation, Mirus Corporation, Roche Madison Inc.. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir G Budker. Retrieved from https://idiyas.com/inventor/vladimir-g-budker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 59

% Patents Active = 55.9


Average Co-Inventor Count = 4.4

ph-index = 19

Forward Citations = 1,080(Granted Patents)

Forward Citations (Not Self Cited) = 1,025(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Madison, WI (US) (1997 - 2008)
  • Middleton, WI (US) (2002 - 2012)

Company Filing History:

goldMedal27 out of 40 
 
Mirus Bio Corporation
 patents
silverMedal21 out of 94 
 
Mirus Corporation
 patents
bronzeMedal7 out of 19 
 
Roche Madison Inc.
 patents
4. 1 out of 1 
 
Miris Bio Corporation
 patent
5. 1 out of 2 
 
Mirns Bio Corporation
 patents
6. 2 out of 834,453 
Other
 patents

Years Active: 1997-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid
Polyampholytes
Gene Expression
Drug Delivery
Polyion Complexes
Intravascular Delivery
Polynucleotide
Micellar Systems
pH Sensitivity
Cell Delivery
Genetic Material
Labile Disulfide Bond
59 patents (USPTO):Explore Patents
1. 8129509 - Method for single-step attachment of a label to target molecules (2012-03-06),
2. 7642248 - Devices and processes for distribution of genetic material to mammalian limb (2010-01-05),
3. 7589059 - Delivery of molecules and complexes to mammalian cells in vivo (2009-09-15),
4. 7524680 - Polyampholytes for delivering polyions to a cell (2009-04-28),
5. 7507722 - Intravascular delivery of nucleic acid (2009-03-24),
6. 7491538 - Gene expression with covalently modified polynucleotides (2009-02-17),
7. 7482160 - Process of making a compound by forming a polymer from a template drug (2009-01-27),
8. 7476401 - Protein and peptide delivery to mammalian cells in vitro (2009-01-13),
9. 7473419 - Intravascular delivery of nucleic acid (2009-01-06),
10. 7470539 - Formation of polyampholytes in the presence of a polyion (2008-12-30),
11. 7435723 - Process for delivery of polynucleotides to the prostate (2008-10-14),
12. 7396919 - Charge reversal of polyion complexes (2008-07-08),
13. 7396821 - Intravascular delivery of nucleic acid (2008-07-08),
14. 7326780 - Compounds and processes for single-pot attachment of a label to nucleic acid (2008-02-05),
15. 7214369 - Devices and processes for distribution of genetic material to mammalian limb (2007-05-08),

Title: The Legacy of Vladimir G Budker: Innovations in Middleton

Introduction: Vladimir G Budker, a distinguished inventor based in Middleton, WI, has made significant contributions to the field of technology and innovation. His work has left a lasting impact on various industries and continues to inspire future generations of inventors.

Latest Patents: Budker's latest patents showcase his commitment to pushing the boundaries of technology. His innovative ideas have led to groundbreaking solutions in areas such as renewable energy, healthcare, and communication systems.

Career Highlights: With a career spanning several decades, Budker has amassed a wealth of experience in research and development. His keen eye for detail and passion for innovation have been instrumental in the success of numerous projects throughout his career.

Collaborations: Budker's collaborative spirit has led to fruitful partnerships with leading companies, research institutions, and universities. By working closely with experts from diverse backgrounds, he has been able to bring his ideas to life and create impactful inventions.

Conclusion: In conclusion, Vladimir G Budker stands as a beacon of innovation in Middleton, WI, and beyond. His dedication to pushing the boundaries of technology and his collaborative approach to invention have solidified his legacy as a pioneering inventor in the modern era.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…